Claims for Patent: RE37336
✉ Email this page to a colleague
Summary for Patent: RE37336
Title: | Method for providing hyaluronic acid |
Abstract: | Disclosed are DNA segments encoding .[.hyaluronic acid synthase which are employed to construct recombinant cells useful in the production of hyaluronate synthase or hyaluronic acid (HA).]. .Iadd.the recombinant DNA segment identified in FIG. 5. .Iaddend.In preferred aspects, chromosomal DNA from Streptococcus equisimilis is partially digested with EcoRI and the resultant fragments are ligated to form recombinant vectors. These vectors are useful in the transformation of host cells such as E. coli and or Streptococcal hosts. .[.Resultant transformants are screened by the novel screening assays to identify colonies which have incorporated HA synthase DNA in a form that is being actively transcribed into the corresponding HA synthase enzyme. These colonies may be selected and employed in the production of the enzyme itself or its product, HA..]. .Iadd.The recombinant DNA segment identified in FIG. 5 is then inserted into a recombinant Streptococcal host for the production of hyaluronic acid (HA)..Iaddend. |
Inventor(s): | Weigel; Paul H. (Edmond, OK), Papaconstantinou; John (Galveston, TX) |
Assignee: | The Board of Regents of the University of Oklahoma (Norman, OK) |
Application Number: | 09/281,107 |
Patent Claims: | 1. A .[.DNA segment isolated from a eukaryotic or prokaryotic source comprising a sequence encoding hyaluronate synthase.]. .Iadd.method for providing hyaluronic acid
employing a recombinant DNA segment, comprising the steps of:
(i) providing recombinant Streptococcal host, wherein the recombinant Streptococcal host contains a plasmid comprising the DNA segment identified in FIG. 5 inserted therein; (ii) culturing the recombinant Streptococcal host under conditions appropriate for the production of hyaluronic acid; and (iii) separating the hyaluronic acid from the recombinant Streptococcal host..Iaddend..[. 2. The DNA segment of claim 1 wherein the encoded hyaluronate synthase comprises Streptococcal hyaluronate synthase..]..[. 3. A recombinant vector which incorporates a recombinant insert comprising a DNA segment in accordance with claim 1..]..[. 4. The recombinant vector of claim 3, further identified as a shuttle vector capable of replication in both a Streptococcal and E. coli host..]..[. 5. A recombinant host comprising the DNA segment of claim 1 or the vector of claim 3..]..[. 6. The recombinant host of claim 5, capable of expressing the DNA segment to produce hyaluronate synthase..]..[. 7. The recombinant host of claim 5, further defined as a Streptococcal or an E. coli host..]..[. 8. The recombinant host of claim 5, capable of expressing the hyaluronate synthase and producing hyaluronic acid..]..[. 9. The recombinant host of claim 5, further defined as a hyaluronidase negative host..]..[. 10. A method of providing hyaluronic acid comprising: (a) providing a recombinant host bearing a recombinant DNA segment encoding a hyaluronate synthase enzyme and capable of expressing the enzyme; (b) culturing the recombinant host in a medium under conditions appropriate for the production of hyaluronate synthase or hyaluronic acid; and (c) separating the hyaluronate synthase or hyaluronic acid from the recombinant host..]. |
Details for Patent RE37336
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Bausch & Lomb Incorporated | VITRASE | hyaluronidase | Injection | 021640 | 05/05/2004 | ⤷ Try a Trial | 2040-03-31 |
Bausch & Lomb Incorporated | VITRASE | hyaluronidase | Injection | 021640 | 12/02/2004 | ⤷ Try a Trial | 2040-03-31 |
Amphastar Pharmaceuticals, Inc. | AMPHADASE | hyaluronidase | Injection | 021665 | 10/26/2004 | ⤷ Try a Trial | 2040-03-31 |
Akorn, Inc. | HYDASE | hyaluronidase | Injection | 021716 | 10/25/2005 | ⤷ Try a Trial | 2040-03-31 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.